Learning Objective: -Consistently employ the latest clinical data and mechanisms of action for new and emerging treatment options for T2D, including GLP-1RAs and GLP- 1RAs/GIPs when developing comprehensive treatment plans
- Provider:Medical Learning Institute, Inc.
- Activity Link: https://learn.mlieducation.org/courses
- Start Date: 2024-04-30 05:00:00
- End Date: 2024-04-30 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours - MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Lilly (Any division) - Amount: 39533.75 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Endocrinology, Diabetes, and Metabolism, Internal Medicine
Subscribe
Login
0 Comments
Oldest